Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study

収録刊行物

被引用文献 (15)*注記

もっと見る

キーワード

問題の指摘

ページトップへ